Shots:
Polpharma Biologics has signed a licensing agreement with Brazil-based Libbs Farmacêutica for an autoimmune biosimilar
Under this strategic partnership, Polpharma Biologics is fully responsible for the development and manufacturing of the product
Libbs will exclusively handle the product’s commercialization, marketing, and distribution in the Brazilian market
Ref: Polpharma Biologics | Image: Polpharma Biologics | Press Release
Related News:- Polpharma Biologics Launches…
